Chimeric Antigen Receptor T Cells in Hematologic Malignancies
Author:
Affiliation:
1. Division of Pharmacy; The University of Texas MD Anderson Cancer Center; Houston Texas
2. Division of Cancer Medicine, Department of Lymphoma/Myeloma; The University of Texas MD Anderson Cancer Center; Houston Texas
Publisher
Wiley
Subject
Pharmacology (medical)
Reference62 articles.
1. Turtle CJ Hanafi L-A Berger C Rate of durable complete response in ALL, NHL, and CLL after immunotherapy with optimized lymphodepletion and defined composition CD19 CAR-T cells 2016 102
2. Park JH Riviere I Wang X Purdon T Sadelain M Brentjens RJ Impact of disease burden on long-term outcome of 19-28z CAR modified T cells in adult patients with relapsed B-ALL 2016 7003
3. Maude SL Teachey DT Rheingold SR Sustained remissions with CD19-specific chimeric antigen receptor (CAR)-modified T cells in children with relapsed/refractory ALL 2016 3011
4. Gardner RA Finney O Smithers H Prolonged functional persistence of CD19 CAR T cell products of defined CD4:CD8 composition and transgene expression determines durability of MRD-negative ALL remission 2016 3048
5. Frey NV Shaw PA Hexner EO Optimizing chimeric antigen receptor (CAR) T cell therapy for adult patients with relapsed or refractory (r/r) acute lymphoblastic leukemia (ALL) 2016 7002
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bayesian network analysis of risk classification strategies in the regulation of cellular products;Artificial Intelligence in Medicine;2024-09
2. High-throughput Image-based Clustering of CAR-T/Tumor Cocultures for Rapid and Facile Hit Identification;2024-08-28
3. Tumour lysis syndrome;Nature Reviews Disease Primers;2024-08-22
4. Improving cell reinfusion to enhance the efficacy of chimeric antigen receptor T-cell therapy and alleviate complications;Heliyon;2024-04
5. Adoptive T cell therapy for solid tumors: current landscape and future challenges;Frontiers in Immunology;2024-03-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3